Truist Lowers DexCom (DXCM) PT to $94 Ahead of Q3 MedTech Sector Preview, Maintains Buy Rating
Business
Archived
•
October 30, 2025
•
Source: https://finance.yahoo.com/rss/topstories - Read Original
Discussion (0)
Please log in to post a comment.
No comments yet. Be the first to share your thoughts!



